Literature DB >> 20206207

Human dendritic cells contain cell surface sialyltransferase activity.

M Guadalupe Cabral1, A Rita Piteira, Zélia Silva, Dário Ligeiro, Reinhard Brossmer, Paula A Videira.   

Abstract

Human monocyte-derived dendritic cells (mo-DCs) express highly sialylated structures, with recognized but poorly understood function in maturation, immunogenicity and endocytosis capacity. We have previously shown that mo-DCs surface sialylation is changeable upon different stimuli, which led us to hypothesise the existence of cell surface (non-intracellular) sialyltransferases, rapidly restoring or altering mo-DC surface sialylation, thus modulating specific functions. Here, we demonstrate that, in the presence of exogenous CMP-Neu5Ac, mo-DCs incorporate considerable amounts of sialic acids into cell surface, predominantly when mo-DCs were previously desialylated or matured. This is a genuine sialyltransferase activity, confirmed by specific inhibition assays, which is not influenced by secreted enzymes. Functionally, the ecto-sialyltransferase activity causes a significant down-regulation of mo-DCs endocytic capacity, without affecting the maturation state. These findings suggest that ecto-sialyltransferases participate in a dynamic control of mo-DC sialylation, with functional repercussions. This activity is possibly related with specific physiological and pathological conditions, as inflammation and infection, contributing to protection and homeostasis regulation. Copyright (c) 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20206207     DOI: 10.1016/j.imlet.2010.02.009

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  10 in total

1.  Post-conversion sialylation of prions in lymphoid tissues.

Authors:  Saurabh Srivastava; Natallia Makarava; Elizaveta Katorcha; Regina Savtchenko; Reinhard Brossmer; Ilia V Baskakov
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-16       Impact factor: 11.205

2.  Contribution of vascular endothelial growth factor receptor-2 sialylation to the process of angiogenesis.

Authors:  P Chiodelli; S Rezzola; C Urbinati; F Federici Signori; E Monti; R Ronca; M Presta; M Rusnati
Journal:  Oncogene       Date:  2017-08-07       Impact factor: 9.867

Review 3.  Role of sialylation of N-linked glycans in prion pathogenesis.

Authors:  Natallia Makarava; Ilia V Baskakov
Journal:  Cell Tissue Res       Date:  2022-01-28       Impact factor: 4.051

4.  The phagocytic capacity and immunological potency of human dendritic cells is improved by α2,6-sialic acid deficiency.

Authors:  M Guadalupe Cabral; Zélia Silva; Dário Ligeiro; Elsa Seixas; Hélio Crespo; Mylène A Carrascal; Mariana Silva; Ana R Piteira; Paulo Paixão; Joseph T Lau; Paula A Videira
Journal:  Immunology       Date:  2013-03       Impact factor: 7.397

5.  Sialylation of Glycosylphosphatidylinositol (GPI) Anchors of Mammalian Prions Is Regulated in a Host-, Tissue-, and Cell-specific Manner.

Authors:  Elizaveta Katorcha; Saurabh Srivastava; Nina Klimova; Ilia V Baskakov
Journal:  J Biol Chem       Date:  2016-06-17       Impact factor: 5.157

6.  Siaα2-3Galβ1- Receptor Genetic Variants Are Associated with Influenza A(H1N1)pdm09 Severity.

Authors:  Alvino Maestri; Vinicius Albuquerque Sortica; Luciana Tovo-Rodrigues; Mirleide Cordeiro Santos; Luana Barbagelata; Milene Raiol Moraes; Wyller Alencar de Mello; Leonor Gusmão; Rita Catarina Medeiros Sousa; Sidney Emanuel Batista Dos Santos
Journal:  PLoS One       Date:  2015-10-05       Impact factor: 3.240

Review 7.  Dendritic cells: a spot on sialic Acid.

Authors:  Hélio J Crespo; Joseph T Y Lau; Paula A Videira
Journal:  Front Immunol       Date:  2013-12-27       Impact factor: 7.561

Review 8.  Multifaceted Role of Sialylation in Prion Diseases.

Authors:  Ilia V Baskakov; Elizaveta Katorcha
Journal:  Front Neurosci       Date:  2016-08-08       Impact factor: 4.677

9.  Targeted O-glycoproteomics explored increased sialylation and identified MUC16 as a poor prognosis biomarker in advanced-stage bladder tumours.

Authors:  Sofia Cotton; Rita Azevedo; Cristiana Gaiteiro; Dylan Ferreira; Luís Lima; Andreia Peixoto; Elisabete Fernandes; Manuel Neves; Diogo Neves; Teresina Amaro; Ricardo Cruz; Ana Tavares; Maria Rangel; André M N Silva; Lúcio Lara Santos; José Alexandre Ferreira
Journal:  Mol Oncol       Date:  2017-03-02       Impact factor: 6.603

Review 10.  The Distinct Roles of Sialyltransferases in Cancer Biology and Onco-Immunology.

Authors:  Marjolaine Hugonnet; Pushpita Singh; Quentin Haas; Stephan von Gunten
Journal:  Front Immunol       Date:  2021-12-17       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.